Loading...

Bioventix PLC

BVXP.L•LSE
Healthcare
Biotechnology
£2665.00
£15.00(0.57%)

Bioventix PLC (BVXP.L) Stock Overview

Explore Bioventix PLC’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 74.4/100

Key Financials

Market Cap139.2M
P/E Ratio17.73
EPS (TTM)$1.48
ROE0.67%
Fundamental Analysis

AI Price Forecasts

1 Week$2835.76
1 Month$3166.73
3 Months$2498.21
1 Year Target$3828.14

BVXP.L Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bioventix PLC (BVXP.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.12, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3828.14.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 17.73 and a market capitalization of 139.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;